All news

Russia’s Convacell vaccine to be effective against stealth Omicron, official says

Indeed, we recorded the development of combined immunity with very high protective properties and complete seroconversion

MOSCOW, March 19. /TASS/. Russia’s Convacell coronavirus vaccine will be effective against the stealth Omicron variant, Head of the Federal Medical Biological Agency (FMBA) Veronika Skvortsova told the Rossiya-24 TV channel on Saturday.

"Indeed, we recorded the development of combined immunity with very high protective properties and complete seroconversion. The share of cases where high titers of immunoglobulin G tagerting N protein were detected is 100%, besides, specific cells and cellular immunity are also developed and central memory cells emerge, which guarantees that the protective effect of the vaccine will remain in place for a long time," she explained.

On Friday, Russia’s Health Ministry registered the Convacell coronavirus vaccine developed by the FMBA’s St.Petersburg Research Institute of Vaccines and Serums.